CME CME Coalition: Congressional Briefing on HIV and CME Thomas Sullivan Sep 30, 2011 1 As part of its mission to raise awareness about the importance of continuing medical education (CME), the CME Coalition held its…
CME CME Coalition Congressional Briefing on Breast Cancer and CME Thomas Sullivan Sep 29, 2011 0 For a typical physician who will practice medicine for 30 to 40 years over the course of his or her career, assessments,…
FDA FDA Guidance on Informed Consent Thomas Sullivan Sep 29, 2011 0 The Office for Human Research Protections (OHRP) and the Food and Drug Administration (FDA) released last month a new guidance,…
FDA FDA Biosimilars Guidance Coming Soon Thomas Sullivan Sep 28, 2011 0 Biologic products developed over the past three decades and approved by the Food and Drug Administration (FDA) now provide…
CMS CMS Rules for Values Based Purchasing Thomas Sullivan Sep 28, 2011 0 The Centers for Medicare and Medicaid Services (CMS) recently issued final rules for its value-based purchasing program for…
Affordable Care Act Affordable Care Act Medical Device Fee’s Cause of 11% Jobs Loss Thomas Sullivan Sep 27, 2011 1 The medical device manufacturing industry contributes to the economy of every state. In 2009, the medical device industry…
Clinical Research FDA Draft Guidance – Oversight of Clinical Investigations: A Risk… Thomas Sullivan Sep 26, 2011 1 The Food and Drug Administration (FDA) announced the publication of a draft guidance titled, “Oversight of Clinical…
CME Elimination of Industry Support for CME an Urban Myth Thomas Sullivan Sep 23, 2011 0 Urban myths come in all shapes and sizes. Recent medical scares include a rogue politican claiming that a vaccine is no good,…
CME Alliance for Continuing Medical Education Moving Ahead with National… Thomas Sullivan Sep 23, 2011 0 According to a recent article from Medical Meetings, the Alliance for Continuing Medical Education “is moving ahead with its plans…
FDA FDA Revises Guidance on Marketed Unapproved Drugs – Enforcement Actions… Thomas Sullivan Sep 22, 2011 1 This week, the Food and Drug Administration (FDA) announced a revision to its 2006 guidance titled “Marketed Unapproved Drugs--…